Iowa State University

Iowa State University
Bioinformatics & Computational Biology Bioinformatics & Computational Biology
Find me on Facebook
MBB Building

The Molecular Biology Building houses two of the eighteen departments which participate in the BCB Graduate Program at Iowa State University.

The BCB Graduate Program

The BCB Graduate Program provides an interdisciplinary research environment where successful collaborations between life science researchers and computational scientists have developed over its 14 year history.

Receive Stipend and Tuition Credits

Choose PhD study in ISU's BCB Graduate program and enter a vibrant learning community supported by world class resources. Entering students enjoy full tuition and health insurance credits, as well as a yearly stipend which can range up to $25,000 depending on the fellowship received. Apply by Jan. 15. FAQs to apply.

Outstanding BCB Faculty

Interdisciplinary research is possible at Iowa State in bioinformatics and computational biology because of the many collaborations among outstanding BCB faculty members.

Got a question or comment? Contact us at (515) 294-5122 or

News & Updates

Two BCB faculty are new AAAS Fellows

Edward Yu, Professor in 3 departments and an associate of the Ames Laboratory, is being honored "For distinguished contributions to the field of efflux transporters, which mediate resistance to a variety of antimicrobials in bacteria."

Current research projects in Yu's lab include antimicrobial resistance in the bacteria that cause gonorrhea and the essential efflux transporters in the bacteria that cause tuberculosis.

Christopher Tuggle, professor of animal science, is being honored "For distinguished contributions to the field of animal genetics and genomics, particularly for the application of transcriptional profiling to study networks controlling porcine immune response."

Tuggle is developing a unique line of immunodeficient pigs as a model for biomedical research. An immuno-deficient pig model would be valuable in testing vaccines and cancer drugs, and in improving therapies for people with immune deficiencies.

Additional information can be found here.